PT  - JOURNAL ARTICLE
AU  - Schijven, Dick
AU  - Postema, Merel C.
AU  - Fukunaga, Masaki
AU  - Matsumoto, Junya
AU  - Miura, Kenichiro
AU  - de Zwarte, Sonja M.C.
AU  - van Haren, Neeltje E.M.
AU  - Cahn, Wiepke
AU  - Hulshoff Pol, Hilleke E.
AU  - Kahn, René S.
AU  - Ayesa-Arriola, Rosa
AU  - de la Foz, Víctor Ortiz-García
AU  - Tordesillas-Gutierrez, Diana
AU  - Vázquez-Bourgon, Javier
AU  - Crespo-Facorro, Benedicto
AU  - Alnæs, Dag
AU  - Dahl, Andreas
AU  - Westlye, Lars T.
AU  - Agartz, Ingrid
AU  - Andreassen, Ole A.
AU  - Jönsson, Erik G.
AU  - Kochunov, Peter
AU  - Bruggemann, Jason M.
AU  - Catts, Stanley V.
AU  - Michie, Patricia T.
AU  - Mowry, Bryan J.
AU  - Quidé, Yann
AU  - Rasser, Paul E.
AU  - Schall, Ulrich
AU  - Scott, Rodney J.
AU  - Carr, Vaughan J.
AU  - Green, Melissa J.
AU  - Henskens, Frans A.
AU  - Loughland, Carmel M.
AU  - Pantelis, Christos
AU  - Weickert, Cynthia Shannon
AU  - Weickert, Thomas W.
AU  - de Haan, Lieuwe
AU  - Brosch, Katharina
AU  - Pfarr, Julia-Katharina
AU  - Ringwald, Kai G.
AU  - Stein, Frederike
AU  - Jansen, Andreas
AU  - Kircher, Tilo T.J.
AU  - Nenadić, Igor
AU  - Krämer, Bernd
AU  - Gruber, Oliver
AU  - Satterthwaite, Theodore D.
AU  - Bustillo, Juan
AU  - Mathalon, Daniel H.
AU  - Preda, Adrian
AU  - Calhoun, Vince D.
AU  - Ford, Judith M.
AU  - Potkin, Steven G.
AU  - Chen, Jingxu
AU  - Tan, Yunlong
AU  - Wang, Zhiren
AU  - Xiang, Hong
AU  - Fan, Fengmei
AU  - Bernardoni, Fabio
AU  - Ehrlich, Stefan
AU  - Fuentes-Claramonte, Paola
AU  - Garcia-Leon, Maria Angeles
AU  - Guerrero-Pedraza, Amalia
AU  - Salvador, Raymond
AU  - Sarró, Salvador
AU  - Pomarol-Clotet, Edith
AU  - Ciullo, Valentina
AU  - Piras, Fabrizio
AU  - Vecchio, Daniela
AU  - Banaj, Nerisa
AU  - Spalletta, Gianfranco
AU  - Michielse, Stijn
AU  - van Amelsvoort, Therese
AU  - Dickie, Erin W.
AU  - Voineskos, Aristotle N.
AU  - Sim, Kang
AU  - Ciufolini, Simone
AU  - Dazzan, Paola
AU  - Murray, Robin M.
AU  - Kim, Woo-Sung
AU  - Chung, Young-Chul
AU  - Andreou, Christina
AU  - Schmidt, André
AU  - Borgwardt, Stefan
AU  - McIntosh, Andrew M.
AU  - Whalley, Heather C.
AU  - Lawrie, Stephen M.
AU  - du Plessis, Stefan
AU  - Luckhoff, Hilmar K.
AU  - Scheffler, Freda
AU  - Emsley, Robin
AU  - Grotegerd, Dominik
AU  - Lencer, Rebekka
AU  - Dannlowski, Udo
AU  - Edmond, Jesse T.
AU  - Rootes-Murdy, Kelly
AU  - Stephen, Julia M.
AU  - Mayer, Andrew R.
AU  - Antonucci, Linda A.
AU  - Fazio, Leonardo
AU  - Pergola, Giulio
AU  - Bertolino, Alessandro
AU  - Díaz-Caneja, Covadonga M.
AU  - Janssen, Joost
AU  - Lois, Noemi G.
AU  - Arango, Celso
AU  - Tomyshev, Alexander S.
AU  - Lebedeva, Irina
AU  - Cervenka, Simon
AU  - Sellgren, Carl M.
AU  - Georgiadis, Foivos
AU  - Kirschner, Matthias
AU  - Kaiser, Stefan
AU  - Hajek, Tomas
AU  - Skoch, Antonin
AU  - Spaniel, Filip
AU  - Kim, Minah
AU  - Kwak, Yoo Bin
AU  - Oh, Sanghoon
AU  - Kwon, Jun Soo
AU  - James, Anthony
AU  - Bakker, Geor
AU  - Knöchel, Christian
AU  - Stäblein, Michael
AU  - Oertel, Viola
AU  - Uhlmann, Anne
AU  - Howells, Fleur M.
AU  - Stein, Dan J.
AU  - Temmingh, Henk S.
AU  - Diaz-Zuluaga, Ana M.
AU  - Pineda-Zapata, Julian A.
AU  - López-Jaramillo, Carlos
AU  - Homan, Stephanie
AU  - Ji, Ellen
AU  - Surbeck, Werner
AU  - Homan, Philipp
AU  - Fisher, Simon E.
AU  - Franke, Barbara
AU  - Glahn, David C.
AU  - Gur, Ruben C.
AU  - Hashimoto, Ryota
AU  - Jahanshad, Neda
AU  - Luders, Eileen
AU  - Medland, Sarah E.
AU  - Thompson, Paul M.
AU  - Turner, Jessica A.
AU  - van Erp, Theo G.M.
AU  - Francks, Clyde
TI  - Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium
AID  - 10.1101/2022.03.01.22271652
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.03.01.22271652
4099  - http://medrxiv.org/content/early/2022/08/24/2022.03.01.22271652.short
4100  - http://medrxiv.org/content/early/2022/08/24/2022.03.01.22271652.full
AB  - Left-right asymmetry is an important organizing feature of the healthy brain that may be altered in schizophrenia, but most studies have used relatively small samples and heterogeneous approaches, resulting in equivocal findings. We carried out the largest case-control study of structural brain asymmetries in schizophrenia, using MRI data from 5,080 affected individuals and 6,015 controls across 46 datasets in the ENGIMA consortium, using a single image analysis protocol. Asymmetry indexes were calculated for global and regional cortical thickness, surface area, and subcortical volume measures. Differences of asymmetry were calculated between affected individuals and controls per dataset, and effect sizes were meta-analyzed across datasets. Small average case-control differences were observed for thickness asymmetries of the rostral anterior cingulate and the middle temporal gyrus, both driven by thinner left-hemispheric cortices in schizophrenia. Analyses of these asymmetries with respect to the use of antipsychotic medication and other clinical variables did not show any significant associations. Assessment of age- and sex-specific effects revealed a stronger average leftward asymmetry of pallidum volume between older cases and controls. Case-control differences in a multivariate context were assessed in a subset of the data (N = 2,029), which revealed that 7% of the variance across all structural asymmetries was explained by case-control status. Subtle case-control differences of brain macro-structural asymmetry may reflect differences at the molecular, cytoarchitectonic or circuit levels that have functional relevance for the disorder. Reduced left middle temporal cortical thickness is consistent with altered left-hemisphere language network organization in schizophrenia.Competing Interest StatementO.A.A. is a consultant to HealthLytix. J.B. has received royalties from UpToDate. D.H.M. is a consultant for Recognify Life Sciences Inc., and Syndesi Therapeutics. A.B. received consulting fees by Biogen and lecture fees by Otsuka, Janssen, and Lundbeck. C.M.D-C. has received honoraria from Exeltis and Sanofi. C.Ar. has been a consultant to or has received honoraria or grants from Acadia, Angelini, Boehringer, Gedeon Richter, Janssen Cilag, Lundbeck, Minerva, Otsuka, Pfizer, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion and Takeda. S.K. receives royalties for cognitive test and training software from Schuhfried, Austria. B.F. has received educational speaking fees from Medice GmbH.Funding StatementThe ENIGMA project is in part supported by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (NIH) (Grant No. U54EB020403). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. D.S., M.C.P., S.E.F. and C.F. [ENIGMA-Laterality] were funded by the Max Planck Society (Germany). R.A-A. [PAFIP] is funded by a Miguel Servet contract from the Carlos III Health Institute (CP18/00003). J.V-B. [PAFIP] has received unrestricted research funding from Instituto de Investigacion sanitaria Valdecilla (IDIVAL): INT/A21/10, INT/A20/04. D.A. [TOP] is funded by the South-Eastern Norway Regional Health Authority (grants 2019107 and 2020086). L.T.W. [TOP] is funded by The Research Council of Norway (223273, 300767), the South-Eastern Norway Regional Health Authority (2019101), and the European Research Council under the European Union's Horizon 2020 research and Innovation program (ERC StG, Grant 802998). O.A.A. [TOP] is funded by the Research Council of Norway (#223273, #275054) and KG Jebsen Stiftelsen, South East Norway Health Authority (2017-112, 2019-108). P.K. [MPRC, Huilong] received support from NIH grants R01MH123163 and R01EB015611. M.J.G. [ASRB, IGP] received funding from NHMRC Project Grants 630471, 1051672, 1081603. C.P. [ASRB] was supported by a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship (1105825), and NHMRC L3 Investigator Grant (1196508). V.D.C. [FBIRN, COBRE] was funded by NIH grants R01MH118695 and NSF 2112455. J.M.F. [FBIRN] was funded by a Senior Research Career Scientist Award, Department of Veterans Affairs. P.F-C. [FIDMAG] is funded by CIBERSAM and by Instituto de Salud Carlos III, co-funded by European Union (ERDF/ESF, 'Investing in your future'): Sara Borrell Research contract (CD19/00149). G.S. [RomeSL] was funded by Italian Ministry of Health RC17-18-19-20-21/A grants. A.N.V. [CAMH] currently receives funding from the National Institute of Mental Health, Canadian Institutes of Health Research, Canada Foundation for Innovation, CAMH Foundation, and the University of Toronto. K.S. [IMH] received support from research grants from the National Healthcare Group, Singapore (SIG/05004; SIG/05028), and the Singapore Bioimaging Consortium (RP C009/2006). Y-C.C. [JBNU] was supported by a grant of the Korean Mental Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HL19C0015) and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI18C2383). U.D. [FOR2107 Muenster] was funded by the German Research Foundation (DFG, grant FOR2107 DA1151/5-1 and DA1151/5-2; SFB-TRR58, Projects C09 and Z02) and the Interdisciplinary Center for Clinical Research (IZKF) of the medical faculty of Muenster (grant Dan3/012/17). J.M.S. [COBRE] was funded by NIH grant 1P20RR021938-01. A.R.M. [COBRE] received funding from NIH grants P30GM122734 and R01MH101512. C.M.D-C. [Madrid] has received funding from Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation (PI17/00481, PI20/00721, JR19/00024). S.Ce. [KaSP] received funding from the Swedish Research Council (Grant No. 523-2014-3467). M.Kir. [Zurich] acknowledges funding from the Swiss National Science Foundation (P2SKP3_178175). T.H. [ESO] was supported by funding from the Canadian Institutes of Health Research (142255), Ministry of Health of the Czech Republic (16-32791A, NU20-04-00393), and Brain & Behavior Research Foundation Young and Independent Investigator Awards. A.Jam. [Oxford] was supported by MRC grant G0500092. P.H. [SWIFT] is supported by a NARSAD grant from the Brain & Behavior Research Foundation (28445) and by a Research Grant from the Novartis Foundation (20A058). R.C.G. [UPENN] received funding through NIH grants 1R01MH117014 and 1R01MH119219. N.J. [ENIGMA] is funded by NIH grant R01MH117601. S.E.M. [ENIGMA] is supported in part by Australian NHMRC APP1172917. J.A.T. [FBIRN, MCIC, COBRE] is supported by NIH grant R01MH121246. Further acknowledgments specific to datasets are listed in the Supplementary Information.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical Committee Faculty of Social Sciences, Radboud University Nijmegen, gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis study made use of 46 separate data sets collected around the world, under a variety of different consent procedures and regulatory bodies, during recent decades. Requests to access the data sets will be considered in relation to the relevant consents, rules and regulations, and can be made via the schizophrenia working group of the ENIGMA consortium: http://enigma.ini.usc.edu/ongoing/enigma-asd-working-group/